Raymond James Maintains Strong Buy on DexCom, Raises Price Target to $154
Portfolio Pulse from richadhand@benzinga.com
Raymond James analyst Jayson Bedford maintains a Strong Buy rating on DexCom (NASDAQ:DXCM) and raises the price target from $140 to $154.
July 28, 2023 | 12:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James maintains a Strong Buy rating on DexCom and raises the price target from $140 to $154, which could positively impact the stock's price.
The raised price target by Raymond James indicates a positive outlook for DexCom. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100